WASHINGTON, DC — A prescription heart rhythm drug used to treat serious ventricular arrhythmias has been recalled nationwide after U.S. regulators said a foreign substance was found in some bottles. Unichem Pharmaceuticals USA Inc., based in New Jersey, is pulling 23,850 bottles of amiodarone hydrochloride tablets from the market.
The U.S. Food and Drug Administration classified the recall as Class II on Nov. 13. That designation means the medicine could cause temporary health problems, but the chance of a serious health consequence is considered remote.
Amiodarone is commonly prescribed for patients with ventricular arrhythmias, which can be life-threatening in some cases. More than 1.2 million amiodarone prescriptions were filled in the United States in 2024, according to estimates from the ClinCalc DrugStats Database.
What the recall covers and which bottles are affected
The recalled product is Amiodarone Hydrochloride Tablets, 200 mg, sold in 60-count bottles. The FDA listing identifies the affected package by NDC number 29300-359-16.
The lot number is ZMRH25054, and the expiration date is July 31, 2028. The agency has not identified the specific foreign substance involved, only that it prompted the recall.
Because the recall involves a large number of bottles distributed nationwide, patients who take amiodarone are being urged to check their medication labels carefully. A bottle with the listed lot number should not be used without first getting guidance from a pharmacist or doctor.
Why amiodarone is prescribed for serious heart rhythm problems
Amiodarone is not a routine heart pill. According to the Mayo Clinic, it is generally used for serious ventricular arrhythmias, especially when other medicines have not worked well enough.
Ventricular arrhythmias begin in the lower chambers of the heart and can range from manageable to dangerous. The Cleveland Clinic notes that some forms can be life-threatening, which is why medication safety matters for patients who rely on this treatment.
That medical context makes recalls like this especially important for people who may be taking the drug under close supervision. Even when the risk of serious injury is judged to be low, any unexpected contaminant or foreign material raises concerns for patients and prescribers.
What the FDA Class II recall means for patients
The FDA uses Class II to describe recalls involving products that may cause temporary or medically reversible effects. In this case, regulators said the probability of a serious health issue is remote, but the drug should still be removed from affected channels.
That does not mean patients should ignore the recall. Instead, the agency is advising people to verify the bottle information against the lot number and product details listed in the notice before taking more tablets.
Anyone who has an affected bottle should contact a pharmacist or doctor for next steps. Patients should not guess based on appearance alone, since the FDA has not said what the foreign substance is or whether it can be seen in the tablets.
How this recall fits into broader drug safety safeguards
Pharmaceutical companies are expected to maintain manufacturing controls that help prevent contamination and other quality problems before products reach consumers. Those safeguards are part of the reason regulators can order recalls when something goes wrong.
Gary Novack, a clinical pharmacologist and drug safety expert, previously told The Healthy that pharmaceutical products are supposed to pass a range of manufacturing tests before release. He said there are “a host of controls” meant to keep medicine safe for patients.
Even with those controls in place, recalls still happen when a batch does not meet safety standards. In this case, the key issue is not an overdose or labeling mistake, but the reported presence of a foreign substance in a widely used prescription medication.
What patients should do if they have the recalled tablets
Patients should compare the information on their bottle with the FDA listing, especially the lot number ZMRH25054 and the 200 mg, 60-count packaging. If those details match, the medication should be set aside until a pharmacist or physician gives instructions.
Because amiodarone is used to manage serious rhythm disorders, people should not stop or replace it on their own without medical advice. A sudden change in heart medication can be risky, particularly for patients who were prescribed it after other treatments did not work.
The safest immediate step is to seek professional guidance and confirm whether a replacement bottle is needed. The recall affects 23,850 bottles nationwide, making it important for patients and caregivers to double-check supplies in homes, pharmacies, and care settings.
Leave a Reply